FindTrial
Sign In

SHR-A2009

DRUG6 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd., Fudan University, Henan Cancer Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

Advanced Breast CancerAdvanced Solid TumorAdvanced Solid TumorsBreast CancerBreast NeoplasmHER2-negative Breast CancerHormone Receptor Positive TumorLung Cancer

Phase 1

A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
NCT05114759
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Solid Tumors
Start: 2022-01-04End: 2024-12-30Target: 132Updated: 2022-10-12
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
CompletedNCT05394818
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Solid Tumor
Start: 2022-07-21End: 2024-04-30Updated: 2024-12-27
A Phase Ib Study of HS-10504 Combined Therapy in NSCLC
Not yet recruitingNCT07414953
Jiangsu Hansoh Pharmaceutical Co., Ltd.Lung Cancer
Start: 2026-03-30End: 2028-11-30Target: 400Updated: 2026-02-17

Phase 2

SNF Platform Study of HR+/ HER2-advanced Breast Cancer
RecruitingNCT05594095
Fudan UniversityAdvanced Breast Cancer, Breast Cancer, Breast Neoplasm +2
Start: 2022-12-30End: 2026-12-01Target: 620Updated: 2024-10-04
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
Not yet recruitingNCT06465238
Henan Cancer HospitalNSCLC
Start: 2024-06-30End: 2027-06-30Target: 30Updated: 2024-06-20
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
RecruitingNCT06649331
Fudan UniversityAdvanced Breast Cancer, Breast Cancer, HER2-negative Breast Cancer +2
Start: 2024-10-21End: 2027-09-01Target: 160Updated: 2026-03-17

Related Papers

Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
2025-12-04
Abstract P2-09-17: Precision medicine based on similarity network fusion (SNF) subtypes of multi-omics in CDK4/6 inhibitor failed HR+/ HER2- advanced breast cancer: the Linux trial
Clinical Cancer Research2025-06-13